Kinetic Studies on the Oxoiron(IV) Complex with Tetradentate Aminopyridine Ligand PDP*: Restoration of Catalytic Activity by Reduction with HO.

08:00 EDT 12th September 2019 | BioPortfolio

Summary of "Kinetic Studies on the Oxoiron(IV) Complex with Tetradentate Aminopyridine Ligand PDP*: Restoration of Catalytic Activity by Reduction with HO."

Oxoiron(IV) is a common catalytic byproduct observed in the oxidation of alkenes by the combination of HO and nonheme iron catalysts including complex , FePDP* (where PDP* = bis(3,5-dimethyl-4-methoxypyridyl-2-methyl)-(,)-2,2'-bipyrrolidine). The oxoiron(IV) species have been proposed to arise by O-O homolysis of the peroxyiron(III) or acylperoxyiron(III) intermediates formed during the presumed Fe-Fe catalytic cycle and have generally been regarded as off-pathway. We generated complex (λ = 730 nm, ε = 350 M cm) directly from and an oxygen atom donor IBX (isopropyl 2-iodoxybenzoate) in acetonitrile in the temperature range from -35 to +25 °C under stopped-flow conditions. Species is metastable (half-life of 2.0 min at +25 °C), and its decay is accelerated in the presence of organic substrates such as thioanisole, alkenes, benzene, and cyclohexane. The reaction with cyclohexane- is significantly slower (KIE = 4.9 ± 0.4), suggesting that a hydrogen atom transfer to is the rate limiting step. With benzene-, no significant isotope effect is observed (KIE = 1.0 ± 0.2), but UV-vis spectra show the concomitant formation of an intense 580 nm band likely due to the Fe(III)-phenolate chromophore, suggesting an electrophilic attack of on the aromatic system of benzene. Treatment of with HO resulted in rapid decay of its 730 nm visible band ( = 102.6 ± 4.6 M s at -20 °C), most likely occurring by a hydrogen atom transfer from HO. In the presence of excess HO, the oxoiron(IV) is transformed into peroxyiron(III), as seen from the formation of a characteristic 550 nm visible band and = 2.22, 2.16, and 1.96 electron paramagnetic resonance (EPR) spectroscopy signals. Reductively formed was able to re-enter the catalytic cycle of alkene epoxidation by HO, albeit with lower yields versus those of oxidatively formed (i.e., + HO) peroxyiron(III) owing to a loss of ca. 40% active iron. As such, the oxoiron(IV) species can be reintroduced to the catalytic cycle with extra HO, acting as an iron reservoir. Alternatively, peroxycarboxylic acids, which have a stronger O-H bond dissociation energy, do not reduce , ensuring that more oxidant is productively employed in substrate oxidation. While this reaction with HO may occur for other nonheme oxoiron(IV) complexes, the only previously reported examples are and , which are reduced by hydrogen peroxide 130- and 2900-fold more slowy, respectively (as in 2012 , 51 ( 22 ), 5376 - 5380 ,
10.1002/anie.201200901 ).


Journal Details

This article was published in the following journal.

Name: Inorganic chemistry
ISSN: 1520-510X


DeepDyve research library

PubMed Articles [13560 Associated PubMed Articles listed on BioPortfolio]

Spectroscopic and reactivity comparisons between nonheme oxoiron(IV) and oxoiron(V) species bearing the same ancillary ligand.

This work directly compares the spectroscopic and reactivity properties of an oxoiron(IV) and an oxoiron(V) complex that are supported by the same neutral tetradentate N-based PyNMe3 ligand. A complet...

Structural implications of the paramagnetically shifted NMR signals from pyridine H atoms on synthetic nonheme Fe=O complexes.

Oxoiron(IV) motifs are found in important intermediates in many enzymatic cycles that involve oxidations. Over half of the reported synthetic nonheme oxoiron(IV) analogs incorporate heterocyclic donor...

Metal-Assisted Delayed Fluorescent Pd(II) Complexes and Phosphorescent Pt(II) Complex Based on 1,2,4Triazolo4,3-pyridine-Containing Ligands: Synthesis, Characterization, Electrochemistry, Photophysical Studies, and Application.

The synthesis and photophysical characterization of a series of tetradentate cyclometalated M(Ph-O-CzPy-R) complexes and their analogues are reported, where M is palladium or platinum and a tetradenta...

Electrocatalytic Reduction of CO to Methanol by Iron Tetradentate Phosphine Complex Through Amidation Strategy.

The iron complex of tetradentate tris[2-(diphenylphosphino) ethyl]phosphine (PP ), [Fe(PP )(MeCN) ](BF ) , was able to electrocatalytically reduce CO to formate with a Faradaic efficiency (FE) of appr...

A further study of pyrolysis of carbon fibre-epoxy composite from hydrogen tank: Search optimization for kinetic parameters via a Shuffled Complex Evolution.

The study of hydrogen fuel cell vehicles is currently one of the popular research topics. However, a vital issue for hydrogen fuel cell vehicles is the hydrogen tank safety when hydrogen tank catch fi...

Clinical Trials [1905 Associated Clinical Trials listed on BioPortfolio]

4-aminopyridine Treatment for Nerve Injury

To evaluate the role of 4-aminopyridine (4-AP) on the course of recovery after peripheral nerve traction and/or crush injury. This study aims to test the hypothesis that 4-aminopyridine sp...

4-aminopyridine Treatment for Nerve Injury From Radical Retro-Pubic Prostatectomy

The purpose of this study is to see if the study drug 4-aminopyridine (4-AP) can help speed up the recovery of peripheral nerve injury after prostatectomy. 4-AP is a potassium channel bloc...

4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine

This phase 2 randomized study will be used to test the efficacy of 4-aminopyridine (4AP) or atenolol to reduce severity and frequency of vestibular and headache symptoms of vestibular migr...

A Single Dose Pharmaco-Diagnostic for Peripheral Nerve Continuity After Trauma

The purpose of this study is to evaluate the role of 4-aminopyridine (4-AP) on the course of recovery after peripheral nerve traction and/or crush injury. The investigational treatment wil...

High Doses of 4-aminopyridine in Clinically Complete Chronic Spinal Cord Injury Patients.

150 patients with clinically complete chronic spinal cord Injury will be included in a randomized, parallel, placebo controlled, multi-centric, phase III trial. Patients will be evaluated ...

Medical and Biotech [MESH] Definitions

Studies designed to examine associations, commonly, hypothesized causal relations. They are usually concerned with identifying or measuring the effects of risk factors or exposures. The common types of analytic study are CASE-CONTROL STUDIES; COHORT STUDIES; and CROSS-SECTIONAL STUDIES.

Works about research studies that evaluate interventions or exposures on biomedical or health-related outcomes. The two main types of clinical studies are interventional studies (clinical trials) and observational studies.

One of the POTASSIUM CHANNEL BLOCKERS, with secondary effect on calcium currents, which is used mainly as a research tool and to characterize channel subtypes.

A transmembrane-protein belonging to the TNF family of intercellular signaling proteins. It is a widely expressed ligand that activates APOPTOSIS by binding to TNF-RELATED APOPTOSIS-INDUCING LIGAND RECEPTORS. The membrane-bound form of the protein can be cleaved by specific CYSTEINE ENDOPEPTIDASES to form a soluble ligand form.

Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.

Quick Search

DeepDyve research library

Searches Linking to this Article